SCHEMBL106041

SCHEMBL106041

CC(=O)OS(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT1 P54687 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.41
TSHR P16473 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.39
ELANE P08246 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ESR1 P03372 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
HMGB1 P09429 1/20 0.39
HPGD P15428 1/20 0.39
GGT1 P19440 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
BLM P54132 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8465178 0.89 KMT2A (0.45) ALDH1A1KMT2ATDP1HSD11B1CES2
SCHEMBL105291 0.81 TSHR (0.44) BCAT1ALDH1A1TSHRSMN1; SMN2HSD17B10
SCHEMBL105014 0.81 TSHR (0.44) BCAT1ALDH1A1KMT2ATSHRSMN1; SMN2
SCHEMBL31215190 0.80 BCAT1 (0.46) BCAT1ALDH1A1KMT2ATSHRSMN1; SMN2
SCHEMBL28496246 0.80 BCAT1 (0.41) BCAT1ALDH1A1KMT2ATSHRSMN1; SMN2
SCHEMBL1764861 0.80 LMNA (0.48) ALDH1A1KMT2AHPGDTDP1CES2
SCHEMBL722599 0.80 BCAT1 (0.46) BCAT1ALDH1A1KMT2ATSHRSMN1; SMN2
SCHEMBL11136204 0.80 ENPP2 (0.46) ALDH1A1KMT2ATSHRSMN1; SMN2ELANE
SCHEMBL27840222 0.79 ELANE (0.45) BCAT1ALDH1A1KMT2ATSHRSMN1; SMN2
SCHEMBL6261806 0.78 BCAT1 (0.44) BCAT1ALDH1A1KMT2ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 867 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116779434-A Etching process for electronic functional element with hole for 5G chip 深圳市盛鸿运科技有限公司 2023-09-19 CN claimed
EP-1099983-B1 Chemically amplified positive resist composition and patterning method SHINETSU CHEMICAL CO (JP) 2014-08-06 EP claimed
US-20070117041-A1 Photosensitive coating for enhancing a contrast of a photolithographic exposure INFINEON TECHNOLOGIES AG (DE) 2007-05-24 US claimed
US-20070105043-A1 Photosensitive coating for enhancing a contrast of a photolithographic exposure QIMONDA AG (DE) 2007-05-10 US claimed
US-20070092829-A1 Photosensitive coating for enhancing a contrast of a photolithographic exposure INFINEON TECHNOLOGIES AG (DE) 2007-04-26 US claimed
WO-2007045498-A2 PHOTOSENSITIVE COATING FOR ENHANCING A CONTRAST OF A PHOTOLITHOGRAPHIC EXPOSURE QIMONDA AG (DE) 2007-04-26 WO claimed
EP-0942329-B1 NOVEL PROCESS FOR PREPARING RESISTS CLARIANT FINANCE BVI LTD (VG) 2002-11-13 EP claimed
US-20010024765-A1 Novel process for preparing resists MERCK PATENT GMBH (DE) 2001-09-27 US claimed
US-6284427-B1 Process for preparing resists CLARIANT FINANCE (BVI) LIMITED (VG) 2001-09-04 US claimed
EP-0942329-A1 NOVEL PROCESS FOR PREPARING RESISTS Clariant International Ltd. (CH) 1999-09-15 EP claimed
EP-4749365-A1 CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2026-05-27 EP disclosed
CN-122072437-A Chemically amplified negative resist composition and resist pattern forming method 信越化学工业株式会社 2026-05-22 CN disclosed
WO-2026100410-A1 IODINE-CONTAINING POLYMERIZABLE COMPOUND AND IODINE-CONTAINING POLYMER 三菱瓦斯化学株式会社 2026-05-15 WO disclosed
US-20260118764-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM AND SILICON-CONTAINING RESIST UNDERLAYER FILM NISSAN CHEMICAL CORPORATION (JP) 2026-04-30 US disclosed
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
EP-0611998-A2 Positive-working radiation-sensitive mixture HOECHST JAPAN LIMITED (JP) 1994-08-24 EP disclosed
US-4401537-A EPOXIDE, ONIUM CATALYST AND 3-GLYCIDOXYPROPYL/TRIETHOXYSILANE; CHEMICAL RESISTANCE; ADHESIVES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1983-08-30 US disclosed
US-4297401-A COMPRISING A MIXTURE OF EPOXY-CONTAINING COMPOUND, AN ONIUM CATALYST, AND A SILANE ANCHORING AGENT; HERMETIC SEALING; SHELF LIFE MINNESOTA MINING & MANUFACTURING COMPANY (US) 1981-10-27 US disclosed
US-4156046-A POLYEPOXIDES, EPOXY-TERMINATED SILANES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1979-05-22 US disclosed
US-4101513-A ONIUM CATALYSTS OF GROUP 5A, 6A OR 7A ATOMS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1978-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118764-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM AND SILICON-CONTAINING RESIST UNDERLAYER FILM SRSF1, MACF1, SRPK1 BCAT1 3119/4885ALDH1A1 3642/4885KMT2A 111/4885
US-20260118767-A1 REVERSE PATTERNING PROCESS EFNA1, EPHA4, ETV6 BCAT1 3360/4885ALDH1A1 4452/4885KMT2A 2548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.